News
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
SAN ANTONIO, July 09, 2025--bioAffinity Technologies' CyPath® Lung detects Stage 1A lung cancer when imaging was inconclusive ...
Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...
Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...
From July, eligible Australians will be screened for lung cancer as part of the nation's first new cancer screening program ...
Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...
The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.
6d
Stacker on MSNHow artificial intelligence is transforming medical imagingVivian Health reports AI is revolutionizing medical imaging, enhancing speed, accuracy, and patient care through advanced ...
Lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States, according to the American Cancer Society. At very early stages, ...
A national lung cancer screening program begins in July, targeting high-risk people without symptoms. This includes people aged between 50 and 70 years who are currently smoking or have quit in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results